CENTRO DE IMAGEM DIAGNÓSTICOS S.A. ("Company" or "Alliar"), pursuant to paragraph 4 of article 157 of Law 6,404/76 and Instruction 358/02 of the Brazilian Securities and Exchange Commission ("CVM"), updates its shareholders and the market in general on the scenario arising from the pandemic of the novel coronavirus (COVID-19).

The Company informs that today it reached the milestone of 80,000 tests performed to diagnose COVID-19. It includes the three main methodologies: RT-PCR, rapid tests, and serological tests.

The Company continues to monitor the effects of the COVID-19 pandemic and will keep its shareholders and the market in general informed of additional initiatives and new developments related to this topic.

São Paulo, June 25th, 2020.

IR Contact

Sami Foguel
CEO and Investor Relations Officer